Ladan Teimoori-Toolabi
Overview
Explore the profile of Ladan Teimoori-Toolabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
543
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallaji M, Allahyari M, Teimoori-Toolabi L, Yasami-Khiabani S, Golkar M, Fard-Esfahani P
Sci Rep
. 2025 Feb;
15(1):5107.
PMID: 39934226
Fc-fusion peptides, also known as peptibodies, are a promising new category of targeted therapeutics that offer alternatives to monoclonal antibodies (mAbs) for cancer treatment. This study focuses on an Fc-fusion...
2.
Farrokhnazar E, Moghbelinejad S, Najafipour R, Teimoori-Toolabi L
Heliyon
. 2025 Feb;
11(3):e41933.
PMID: 39931465
Background: Colorectal cancer (CRC) is the third most frequently diagnosed malignancy worldwide. Currently, irinotecan (CPT-11) is used alone or in combination with other drugs to treat patients with advanced CRC....
3.
Shoushtari M, Salehi-Vaziri M, Kadkhodazadeh M, Teimoori A, Arashkia A, Roohvand F, et al.
Int Immunopharmacol
. 2025 Jan;
148:114032.
PMID: 39832457
Dengue virus (DENV) remains a significant public health threat in tropical and subtropical regions, with effective antiviral treatments and vaccines still not fully established despite extensive research. A critical aspect...
4.
Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar M, Rahimi A, Teimoori-Toolabi L, et al.
AMB Express
. 2024 May;
14(1):53.
PMID: 38722404
Using herpes simplex virus type 1 (HSV-1) as a therapeutic tool has recently emerged as a promising strategy for enhancing the treatment of various cancers, particularly those associated with the...
5.
Khalili E, Afgar A, Rajabpour A, Aghaee-Bakhtiari S, Jamialahmadi K, Teimoori-Toolabi L
Heliyon
. 2023 Dec;
9(11):e21775.
PMID: 38045156
Background: Colorectal cancer, is one of most prevalent the cancer in the world. 5-Fluorouracil is a standard chemotherapeutic drug while the acquisition of resistance to 5-Fluorouracil is one of the...
6.
Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar M, Teimoori-Toolabi L, Azadmanesh K
PLoS One
. 2023 Oct;
18(10):e0286231.
PMID: 37862369
Oncolytic viruses (OVs) have emerged as a novel cancer treatment modality, which selectively target and kill cancer cells while sparing normal ones. Among them, engineered Herpes simplex virus type 1...
7.
Nejatipour Z, Teimoori-Toolabi L, Sarrami Forooshani R, Shokrollahi Barough M, Farahmand M, Biglari A, et al.
Cancer Biomark
. 2023 Jul;
38(1):37-47.
PMID: 37522197
Breast cancer is the most common malignancy in women worldwide. Administration of oncolytic viruses is one of the novel promising cancer therapy approaches. Replication of these viruses is usually limited...
8.
Khatami F, Shahriari S, Aminimoghaddam S, Klashami Z, Farahani M, Teimoori-Toolabi L, et al.
Epigenomics
. 2023 Jun;
15(8):507-516.
PMID: 37345350
Some gene expression regulation in cancers can be controlled by epigenetic change like methylation. promoter methylation and expression were evaluated in endometrial cancer. The study was run on 39 tumor...
9.
Shahbazi B, Mafakher L, Arab S, Teimoori-Toolabi L
J Biomol Struct Dyn
. 2023 Apr;
42(2):918-934.
PMID: 37114408
Kallistatin (KL) is a member of the serine proteinase inhibitor (serpin) family regulating oxidative stress, vascular relaxation, inflammation, angiogenesis, cell proliferation, and invasion. The heparin-binding site of Kallistatin has an...
10.
Sheikholeslami S, Zarif-Yeganeh M, Farashi S, Azizi F, Kheradmand Kia S, Teimoori-Toolabi L, et al.
Iran J Public Health
. 2022 Nov;
50(12):2461-2472.
PMID: 36317025
Background: The tumor suppressor genes play a critical role in cellular and molecular mechanisms such as cell cycle processes, cell differentiation and apoptosis. Aberrant DNA methylation of tumor suppressor genes...